BioMarin Pharmaceutical (BMRN) News Today $63.69 +0.41 (+0.65%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period What To Expect From BioMarin Pharmaceutical’s (BMRN) Q1 EarningsApril 30 at 5:24 AM | finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Hsbc Holdings PLCHsbc Holdings PLC trimmed its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 2.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,530 shares of the biotechnology compApril 30 at 5:09 AM | marketbeat.comBioMarin Pharmaceutical Inc. (BMRN): Among Billionaire Andreas Halvorsen’s Stock Picks With Huge Upside PotentialApril 29 at 12:50 PM | insidermonkey.comSusquehanna Fundamental Investments LLC Buys New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Susquehanna Fundamental Investments LLC bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 169,479 shares of the biotechnology compaApril 29 at 6:23 AM | marketbeat.comJump Financial LLC Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Jump Financial LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 77.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,431 shares of the biotApril 29 at 3:58 AM | marketbeat.comEnvestnet Asset Management Inc. Reduces Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Envestnet Asset Management Inc. reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 14.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,121 shares of the biotechnology company's stoApril 28 at 3:15 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Nebula Research & Development LLCNebula Research & Development LLC cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 18.1% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 43,185 shares of the biotechnology company's stock after selling 9,514 shares duApril 27 at 6:57 AM | marketbeat.com7,908 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Syon Capital LLCSyon Capital LLC purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 7,908 shares of the biotechnology company's stocApril 27 at 5:59 AM | marketbeat.comTower Research Capital LLC TRC Acquires 13,426 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Tower Research Capital LLC TRC grew its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 376.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 16,992 shares of the biotechnology company's stock after purchasinApril 27 at 5:09 AM | marketbeat.comCredit Industriel ET Commercial Invests $2.30 Million in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Credit Industriel ET Commercial acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 35,013 shares of the biotechnology company's stock, valued at approximately $April 26, 2025 | marketbeat.comFirst Trust Advisors LP Has $41.41 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)First Trust Advisors LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 34.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 629,985 shares of the biotechnology company's stocApril 26, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Recommendation of "Moderate Buy" by AnalystsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-four analysts that are covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy ratApril 26, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Position Lifted by MetLife Investment Management LLCMetLife Investment Management LLC lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 9.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 107,403 shares of the biotechnoApril 25, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Has $3.65 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)J. Safra Sarasin Holding AG decreased its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 55,472 shares oApril 24, 2025 | marketbeat.com4,531 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Forum Financial Management LPForum Financial Management LP acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,531 shares ofApril 24, 2025 | marketbeat.comCANADA LIFE ASSURANCE Co Has $11.23 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)CANADA LIFE ASSURANCE Co reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 19.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 171,018 shares of theApril 24, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Rating of "Moderate Buy" from BrokeragesApril 24, 2025 | americanbankingnews.comBMRN Quantitative Stock Analysis - Benjamin GrahamApril 24, 2025 | nasdaq.comBioMarin Pharmaceutical Inc. (BMRN): Among Takeover Rumors Hedge Funds Are BuyingApril 24, 2025 | msn.comImplied Volatility Surging for BioMarin Stock OptionsApril 23, 2025 | msn.comAvoro Capital Advisors LLC Sells 575,515 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Avoro Capital Advisors LLC lowered its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 28.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 1,462,500 shares of the biotechnology company's stock after selling 575,515 sharApril 23, 2025 | marketbeat.comTownsquare Capital LLC Invests $296,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Townsquare Capital LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,501 shares of the biotechnology company'sApril 23, 2025 | marketbeat.comCapital Research Global Investors Boosts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Capital Research Global Investors raised its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 23.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,991,772 shares ofApril 22, 2025 | marketbeat.comCanada Pension Plan Investment Board Acquires 79,400 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Canada Pension Plan Investment Board grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 20.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 474,500 shares of the biotechnoloApril 22, 2025 | marketbeat.comGabelli Funds LLC Has $1.34 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Gabelli Funds LLC grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 58.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 20,339 shares of the biotechnology company's stock after acquiring an additional 7,500 shares dApril 22, 2025 | marketbeat.comCarbahal Olsen Financial Services Group LLC Takes Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Carbahal Olsen Financial Services Group LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 4,975 shares of theApril 21, 2025 | marketbeat.com680,594 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by Marshall Wace LLPMarshall Wace LLP purchased a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 680,594 shares of the biotechnology company's stock, valued at approximately $4April 20, 2025 | marketbeat.comInvesco Ltd. Sells 6,338,291 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Invesco Ltd. trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 92.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 504,781 shares of the biotechnology companyApril 20, 2025 | marketbeat.comResearch Analysts Offer Predictions for BMRN Q1 EarningsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Equities researchers at William Blair dropped their Q1 2025 EPS estimates for BioMarin Pharmaceutical in a research note issued on Monday, April 14th. William Blair analyst S. Corwin now forecasts that the biotechnology company will earnApril 19, 2025 | marketbeat.comCerity Partners LLC Sells 31,404 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Cerity Partners LLC decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 52.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 27,935 shares of the biotechnology company's stock after sellApril 19, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Cut to "Buy" at StockNews.comStockNews.com cut BioMarin Pharmaceutical from a "strong-buy" rating to a "buy" rating in a report on Thursday.April 19, 2025 | marketbeat.comBridgewater Associates LP Raises Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Bridgewater Associates LP boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 112.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 302,480 shares ofApril 18, 2025 | marketbeat.comBioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ETApril 17, 2025 | prnewswire.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Dodge & CoxDodge & Cox increased its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 6.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 14,746,235 shares of the biotechnology company's stock after purchasing an additional 847,917 shaApril 17, 2025 | marketbeat.comXTX Topco Ltd Increases Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)XTX Topco Ltd increased its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 161.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,010 shares of the biotechnology company's stock after acquirApril 17, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Rockefeller Capital Management L.P.Rockefeller Capital Management L.P. boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 302,500 shares of the biotApril 17, 2025 | marketbeat.comBioMarin Pharmaceutical (BMRN) Expected to Announce Earnings on WednesdayBioMarin Pharmaceutical (NASDAQ:BMRN) will be releasing earnings before the market opens on Wednesday, April 23, Financial Modeling Prep reports.April 17, 2025 | marketbeat.comUnpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics StocksApril 16, 2025 | finance.yahoo.comIcon Advisers Inc. Co. Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Icon Advisers Inc. Co. purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 13,000 shares of the biotechnology company's stock, valued aApril 16, 2025 | marketbeat.comRenaissance Technologies LLC Buys 17,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Renaissance Technologies LLC lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 435,871 shares of the biotechnology company's stock after buying an additionApril 14, 2025 | marketbeat.comLegal & General Group Plc Has $56.59 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Legal & General Group Plc lowered its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 41.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 860,927 shares of the biotechnology company's stockApril 14, 2025 | marketbeat.comAPG Asset Management N.V. Buys 113,655 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)APG Asset Management N.V. grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 587.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 132,987 shares of the biotechnology company'sApril 13, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 1-Year Low - Here's What HappenedBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 12-Month Low - Should You Sell?April 12, 2025 | marketbeat.comResona Asset Management Co. Ltd. Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Resona Asset Management Co. Ltd. bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 73,480 shares of the biotechnology company's stock,April 11, 2025 | marketbeat.comAlliancebernstein L.P. Sells 22,055 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Alliancebernstein L.P. lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 7.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 257,385 shares of the biotechnology company's stock after selling 22,055 shares during the period.April 11, 2025 | marketbeat.com6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic VolatilityApril 11, 2025 | fool.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,817 shares of the biotechnologyApril 8, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 31.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,623 shares of the biotechnology companApril 7, 2025 | marketbeat.comGeode Capital Management LLC Has $215.78 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Geode Capital Management LLC grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,288,778 shares of the biotechnology company'sApril 7, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Sets New 52-Week Low - Here's What HappenedBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 52-Week Low - What's Next?April 6, 2025 | marketbeat.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.350.85▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼2011▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today EXEL News Today NBIX News Today EXAS News Today RGEN News Today HALO News Today MDGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMRN Stock Free BMRN Stock Alerts